Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03412565
What this trial is testing

Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 265
Large-scale testing (Phase 3)Active Not RecruitingNCT03246529
What this trial is testing

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
BioLineRx, Ltd. 180
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Early research (Phase 1)Study completedNCT05974982
What this trial is testing

Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers

Who this might be right for
Venous Leg Ulcer
Jinnah Postgraduate Medical Centre 48
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Not applicableUnknownNCT03938896
What this trial is testing

PRP IN Planter Fascitis

Who this might be right for
Chronic Plantar Fasciitis
Mansoura University 50
Early research (Phase 1)Study completedNCT00477035
What this trial is testing

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Who this might be right for
LeukemiaMultiple Myeloma
Sally Arai 22
Not applicableNot Yet RecruitingNCT07783347
What this trial is testing

Platelet-Rich Plasma Alone Versus PRP Plus Low-Intensity Shock Wave Therapy for Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Benha University 80
Testing effectiveness (Phase 2)UnknownNCT06550752
What this trial is testing

Erectile Dysfunction Treatment Using Stem Cells

Who this might be right for
Erectile Dysfunction
COR clinic of Regenerative Medicine 30
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT02693535
What this trial is testing

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
American Society of Clinical Oncology 4,200
Not applicableApproved For MarketingNCT05463939
What this trial is testing

Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Large-scale testing (Phase 3)Active Not RecruitingNCT04934475
What this trial is testing

MInimal Residual Disease Adapted Strategy

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 791
Testing effectiveness (Phase 2)Study completedNCT02192775
What this trial is testing

UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus

Who this might be right for
Multiple Myeloma
University of Arkansas 2
Large-scale testing (Phase 3)Study completedNCT02257957
What this trial is testing

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

Who this might be right for
Dry EyeSjogren Syndrome
Universidad Nacional de Colombia 30
Large-scale testing (Phase 3)Study completedNCT01497522
What this trial is testing

Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123
What this trial is testing

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Very early researchLooking for participantsNCT07085559
What this trial is testing

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

Who this might be right for
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL)
Anhui Provincial Hospital 36
Not applicableStudy completedNCT05335824
What this trial is testing

The Effect of Autologous Platelet Concentrations on Orthodontic Treatment Time

Who this might be right for
Class II Division 1 Malocclusion
Damascus University 60
Large-scale testing (Phase 3)Ended earlyNCT00256776
What this trial is testing

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Who this might be right for
Multiple Myeloma
European Society for Blood and Marrow Transplantation 269
Next Page